GRI Bio Expands At-The-Market Equity Offering Capacity

Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potentialThe latest announcement is out from GRI Bio ( (GRI) ). On January 9, 2026, GRI Bio, Inc. filed a prospectus supplement to increase the maximum amount of common stock it may issue under its at-the-market offering agreement with H.C. Wainwright & Co. to an aggregate of $7.38 million in new shares, on top of approximately $6.17 million of stock already sold under the program. The company also obtained a waiver of certain provisions in a December 11, 2025 securities purchase agreement to allow further issuances under this at-the-market facility, and its counsel Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. issued a legal opinion confirming that shares sold pursuant to the program will be validly issued, fully paid and nonassessable, underscoring GRI Bio’s continued reliance on equity issuance as a funding mechanism and clarifying the legal framework for investors participating in these offerings. The most recent analyst rating on (GRI) stock is a Hold with a $0.29 price target. To see the full list of analyst forecasts on GRI Bio stock, see the GRI Stock Forecast page. Spark’s Take on GRI Stock According to Spark, TipRanks’ AI Analyst, GRI is a Neutral. The score is held down primarily by weak financial performance (heavy losses and ongoing cash burn) and bearish technical trend/momentum. Valuation is constrained by unprofitable earnings and no dividend support. Offsetting these risks, recent corporate updates (positive Phase 2a data and new financing) provide incremental support but do not overcome the current financial and trend weakness. To see Spark’s full report on GRI stock, click here. More about GRI Bio GRI Bio, Inc. is a Delaware-incorporated company that issues common stock and accesses the capital markets through at-the-market equity offerings arranged with investment bank H.C. Wainwright & Co., LLC, indicating a financing strategy focused on incremental share sales into the public market. Average Trading Volume: 1,920,472 Technical Sentiment Signal: Sell Current Market Cap: $3.02M Find detailed analytics on GRI stock on TipRanks’ Stock Analysis page.